SanBio initially brought on board Professor Hideyuki Okano (current Dean, Keio University School of Medicine), one of the world’s leading authorities in regenerative medicine, as the founding scientist of our company. Dr. Okano has worked with the company on the rapidly-growing body of science in this field since the Company’s inception.
More recently, SanBio was joined by Shinya Hirata, who previously involved in drug discovery and pharmacological research as a researcher and has extensive knowledge and experience in the medical affairs field, and Keizo Nakada, who has abundant knowledge and experience related to the stable production and supply of pharmaceutical products, to head its R&D department and manufacturing department, respectively. From research through clinical testing and commercial scale production, we believe SanBio has the world’s top team in Cell Therapy Medicine (MSC implantation)
